Mesonero F, Zabana Y, Fernández-Clotet A, Solá A, Caballol B, Leo-Carnerero E, García MJ, Bertoletti F, Bastida G, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Sáiz-Chumillas RM, González-Partida I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benítez JM, Rubín de Célix C, Tejido C, Brunet E, Hernandez-Camba A, Suárez C, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro M, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-Rey I, López-Sanromán A, Albillos A, Barreiro-de Acosta M
Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.
Gisbert JP, Donday MG, Riestra S, Lucendo AJ, Benítez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo Carnerero E, Merino O, Nantes Castillejo Ó, Navarro P, Van Domselaar M, Gutiérrez A, Alonso-Abreu I, Mejuto R, Fernández-Salazar L, Iborra M, Martín-Arranz MD, Pineda JR, Sampedro MJ, Serra Nilsson K, Bouhmidi A, Batista L, Muñoz Villafranca C, Rodríguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marín Jiménez I, Torrella E, Vera Mendoza M, Casanova MJ, de Francisco R, Arias-González L, Marín Pedrosa S, García-Bosch O, García-Alonso FJ, Delgado-Guillena P, García MJ, Torrealba L, Núñez-Ortiz A, Vicuña Arregui M, Bosca-Watts MM, Blázquez I, Acosta D, Garre A, Baldán M, Martínez C, Barreiro-de Acosta M, Domènech E, Esteve M, García-Sánchez V, Nos P, Panés J, Chaparro M
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Baldan-Martin, M, Azkargorta, M, Aransay, A, Gil-Redondo, R, Moreno-Indias, I, Iloro, I, Martínez, PJ, Soleto,, Orejudo, M, Ramírez, C, Lucendo, AJ, Gutiérrez, CR, Gutiérrez, A, Martin-Arranz, E, Bujanda, L, Rodríguez-Lago,, de Francisco, RM, Iglesias-Flores, E, Bermejo, F, Van Domselaar, M, García, MJ, Salazar, LF, Garcia-Alonso, JF, Calvet, X, Torrealba, L, Rey, IB, Pallarés, H, Ber, Y, Carnerero, EL, Casanova, MJ, Millet, O, Elortza, F, Mato, JM, Tinahones, FJ, Chaparro, M, Gisbert, JP
Multi-Omics Biomarkers for Predicting Therapeutic Efficacy in Inflammatory Bowel Disease: Advancing Towards Tailored Treatments
Lluansí A, Llirós M, Carreras-Torres R, Bahí A, Capdevila M, Feliu A, Vilà-Quintana L, Elias-Masiques N, Cueva E, Peries L, Torrealba L, Miquel-Cusachs JO, Sàbat M, Busquets D, López C, Delgado-Aros S, Garcia-Gil LJ, Elias I, Aldeguer X
Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study
Mesonero F, Zabana Y, Fernández-Clotet A, Leo-Carnerero E, Caballol B, Núñez-Ortiz A, García MJ, Bertoletti F, Mínguez A, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Sáiz-Chumillas RM, González I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benítez JM, Rubín de Célix C, Tejido C, Brunet E, Hernández-Camba A, Suárez C, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro M, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-Rey I, López-Sanromán A, Albillos A, Barreiro-de Acosta M
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Lluansí, A, Llirós, M, Carreras-Torres, R, Bahí, A, Capdevila, M, Feliu, A, Vilà-Quintana, L, Elias-Masiques, N, Cuevas, E, Peries, L, Torrealba, L, Cusachs, JOM, Sàbat, M, Casals, DB, Núñez, CL, Delgado-Aros, S, Garcia-Gil, JL, Elias, I, Aldeguer, X
Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome assessed by high-throughput sequencing of the 16S rRNA gene: A pilot study
EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32, 125-126
Gómez-Labrador, C, Ricart, E, Iborra, M, Iglesias, E, Martín-Arranz, MD, de Castro, L, De Francisco, R, García-Alonso, FJ, Sanahuja, A, Gargallo-Puyuelo, CJ, Mesonero, F, Casanova, MJ, Mañosa, M, Rivero, M, Calvo, M, Sierra-Ausin, M, González-Muñoza, C, Calvet, X, García-López, S, Guardiola, J, García, LA, Márquez-Mosquera, L, Gutiérrez, A, Zabana, Y, Navarro-Llavat, M, Poyatos, RL, Piqueras, M, Torrealba, L, Bermejo, F, Ponferrada-Díaz, A, Pérez-Calle, JL, Barreiro-de Acosta, M, Tejido, C, Cabriada, JL, Marín-Jiménez, I, Roncero, O, Ber, Y, Fernández-Salazar, L, Aler, BC, Lucendo, AJ, Llaó, J, Bujanda, L, Villafranca, CM, Domènech, E, Chaparro, M, Gisbert, JP
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Barreiro-de Acosta, M, Skybalo, S, Rodríguez, C, García-López, S, Martín-Arranz, MD, Torrealba, L, Iglesias-Flores, E, Arguelles-Arias, F, Ber, Y, Shevchuk, V, Castro-Fernandez, C, Castro-Palomino, JC, Kurz, G, Heredia, A
Evaluation of safety, pharmacokinetics and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis: A Phase Ib/IIa, randomized, double blind, placebo controlled clinical trial
